SCHEMBL27965915

SCHEMBL27965915

[N-]=[N+]=Nc1ccnc(CC(=O)O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRP O00591 2/20 0.41
▸ GABRD O14764 2/20 0.41
▸ GABRA1 P14867 2/20 0.41
▸ GABRB1 P18505 2/20 0.41
▸ GABRG2 P18507 2/20 0.41
▸ GABRB3 P28472 2/20 0.41
▸ GABRA5 P31644 2/20 0.41
▸ GABRA3 P34903 2/20 0.41
▸ GABRA2 P47869 2/20 0.41
▸ GABRB2 P47870 2/20 0.41
▸ GABRA4 P48169 2/20 0.41
▸ GABRE P78334 2/20 0.41
▸ GABRA6 Q16445 2/20 0.41
▸ GABRG1 Q8N1C3 2/20 0.41
▸ GABRG3 Q99928 2/20 0.41
▸ GABRQ Q9UN88 2/20 0.41
▸ CYP51A1 Q16850 1/20 0.35
▸ CYP2C9 P11712 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ NAPRT Q6XQN6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18986848 0.80 CYP51A1 (0.33) CYP51A1CYP2C9TP53CA12CA1
SCHEMBL18986772 0.77 PDE4A (0.33) CYP51A1CYP2C9TP53CA12CA1
SCHEMBL18986863 0.77 CYP51A1 (0.36) CYP51A1CYP2C9TP53CA12CA1
SCHEMBL13754453 0.73 CA2 (0.50) CYP51A1TP53CA1CA2CA9
SCHEMBL28097360 0.73 RAD51 (0.32) —
SCHEMBL27945227 0.72 AKR1B1 (0.48) NAPRTCA2AKR1B1GAAMEN1
SCHEMBL7914812 0.69 GABRP (0.44) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL17396955 0.69 KDM4E (0.53) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL3548760 0.69 KDM4E (0.47) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL28803719 0.69 KDM4E (0.45) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103958475-B Heteroaryl hydroxamic acid derivatives and their use in the treatment, alleviation or prevention of viral diseases F. HOFFMANN-LA ROCHE AG (CH) 2015-11-25 — — CN disclosed
CN-103958521-A Pyrimidin-4-one derivatives and their use in the treatment, alleviation or prevention of viral diseases HOFFMANN LA ROCHE 2014-07-30 — — CN disclosed
CN-103958475-A Heteroaryl hydroxamic acid derivatives and their use in the treatment, alleviation or prevention of viral diseases HOFFMANN LA ROCHE 2014-07-30 — — CN disclosed
Send feedback